0810 Seres

Product Development

Phase II learnings set up microbiome play Seres for Phase III success

New data keep Seres ahead of microbiome competition in C. difficile race

Improved diagnostic, higher dose set up Seres for Phase III success in C. difficile infection following SER-109’s Phase II miss in 2016. 

Aug 11, 2020 | 12:57 AM GMT

Seres parlayed lessons learned from

Read the full 580 word article

How to gain access

Continue reading with a
two-week free trial.